NCT00171613View on ClinicalTrials.gov

A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

October 31, 2005

Conditions
Hypothalamic Obesity
Interventions
DRUG

Octreotide

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY